5,342
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Daily Impact of COPD in Younger and Older Adults: Global Online Survey Results from over 1,300 Patients

, , &
Pages 419-428 | Received 20 May 2020, Accepted 23 Jun 2020, Published online: 08 Jul 2020

References

  • Celli B, Blasi F, Gaga M, et al Perception of symptoms and quality of life - comparison of patients' and physicians' views in the COPD MIRROR study. Int J Chron Obstruct Pulmon Dis. 2017;12:2189–2196. doi:10.2147/COPD.S136711.
  • Rennard S, Decramer M, Calverley PM, et al. Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey. Eur Respir J. 2002;20(4):799–805. doi:10.1183/09031936.02.03242002.
  • Fletcher MJ, Upton J, Taylor-Fishwick J, et al. COPD uncovered: an international survey on the impact of chronic obstructive pulmonary disease [COPD] on a working age population. BMC Public Health 2011;11:612. doi:10.1186/1471-2458-11-612.
  • Barr RG, Celli BR, Martinez FJ, et al. Physician and patient perceptions in COPD: The COPD Resource Network Needs Assessment survey. Am J Med. 2005;118(12):1415. doi:10.1016/j.amjmed.2005.07.059.
  • Kim SJ, Lee J, Park YS, et al. Age-related annual decline of lung function in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2015;11:51–60. doi:10.2147/COPD.S95028.
  • Schnell K, Weiss CO, Lee T, et al. The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999–2008. BMC Pulm Med. 2012;12(1):26. doi:10.1186/1471-2466-12-26.
  • Brandt CL. Study of older adults' use of self-regulation for COPD self-management informs an evidence-based patient teaching plan. Rehabil Nurs. 2013;38(1):11–23. doi:10.1002/rnj.56.
  • Buist AS, McBurnie MA, Vollmer WM, et al., on behalf of the BOLD Collaborative Research Group. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007;370(9589):741–750. doi:10.1016/S0140-6736(07)61377-4.
  • Sullivan J, Pravosud V, Mannino DM, et al National and state estimates of COPD morbidity and mortality - United States, 2014–2015. Chronic Obstr Pulm Dis. 2018;5(4):324–333. doi:10.15326/jcopdf.5.4.2018.0157.
  • Sanchez-Salcedo P, Divo M, Casanova C, et al. Disease progression in young patients with COPD: rethinking the Fletcher and Peto model. Eur Respir J. 2014;44(2):324–331. doi:10.1183/09031936.00208613.
  • Jones PW, Brusselle G, Dal Negro RW, et al. Health-related quality of life in patients by COPD severity within primary care in Europe. Respir Med. 2011;105(1):57–66. doi:10.1016/j.rmed.2010.09.004.
  • Hu J, Meek P. Health-related quality of life in individuals with chronic obstructive pulmonary disease. Heart Lung 2005;34(6):415–422. doi:10.1016/j.hrtlng.2005.03.008.
  • Phan T, Carter O, Waterer G, et al. Determinants for concomitant anxiety and depression in people living with chronic obstructive pulmonary disease. J Psychosom Res. 2019;120:60–65. doi:10.1016/j.jpsychores.2019.03.004.
  • Osman IM, Godden DJ, Friend JA, et al. Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease. Thorax 1997;52(1):67–71. doi:10.1136/thx.52.1.67.
  • Domingo-Salvany A, Lamarca R, Ferrer M, et al. Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002;166(5):680–685. doi:10.1164/rccm.2112043.
  • Barr RG, Celli BR, Mannino DM, et al. Comorbidities, patient knowledge, and disease management in a national sample of patients with COPD. Am J Med. 2009;122(4):348–355. doi:10.1016/j.amjmed.2008.09.042.
  • Molimard M, Colthorpe P. Inhaler devices for chronic obstructive pulmonary disease: insights from patients and healthcare practitioners. J Aerosol Med Pulm Drug Deliv. 2015;28(3):219–228. doi:10.1089/jamp.2014.1142.
  • Titmarsh S, Poliziani M, Russell RE. Breathing new life into chronic obstructive pulmonary disease (COPD)-results from an online survey of UK patients. Int J Chron Obstruct Pulmon Dis. 2019;14:2799–2807. doi:10.2147/COPD.S222139.
  • Dhand R, Mahler DA, Carlin BW, et al. Results of a patient survey regarding COPD knowledge, treatment experiences, and practices with inhalation devices. Respir Care 2018;63(7):833–839. doi:10.4187/respcare.05715.
  • Barnes N, Calverley PMA, Kaplan A, et al. Chronic obstructive pulmonary disease and exacerbations: patient insights from the global Hidden Depths of COPD survey. BMC Pulm Med. 2013;13(1):54. doi:10.1186/1471-2466-13-54.
  • Martinez CH, Diaz AA, Parulekar AD, et al. Age-related differences in health-related quality of life in COPD: an analysis of the COPDGene and SPIROMICS cohorts. Chest 2016;149(4):927–935. doi:10.1016/j.chest.2015.11.025.
  • Jones PW. St. George’s Respiratory Questionnaire Original English Version [Internet]. 2003. [cited 2020 March 12]. Available from: http://www.healthstatus.sgul.ac.uk/SGRQ_download/Original%20English%20version.pdf.
  • RAND Corporation. SF-36 Questionnaire [Internet]. 2016. [cited 2020 March 12]. Available from: https://clinmedjournals.org/articles/jmdt/jmdt-2-023-figure-1.pdf.
  • Pakhale S, Wood-Dauphinee S, Spahija A, for the Respiratory Health Network of the FRSQ, et al. Validation of a new questionnaire with generic and disease-specific qualities: the McGill COPD Quality of Life Questionnaire. Can Respir J. 2012;19(6):367–372. doi:10.1155/2012/914138.
  • McKenna SP, Meads DM, Doward LC, et al. Development and validation of the living with chronic obstructive pulmonary disease questionnaire. Qual Life Res. 2011;20(7):1043–1052. doi:10.1007/s11136-011-9850-6.
  • Prescott E, Lange P, Vestbo J. Socioeconomic status, lung function and admission to hospital for COPD: results from the Copenhagen City Heart Study. Eur Respir J. 1999;13(5):1109–1114. doi:10.1034/j.1399-3003.1999.13e28.x.
  • Hanlon P, Nicholl BI, Jani BD, et al. Frailty and pre-frailty in middle-aged and older adults and its association with multimorbidity and mortality: a prospective analysis of 493 737 UK Biobank participants. Lancet Public Health 2018;3(7):e323–e332. doi:10.1016/S2468-2667(18)30091-4.
  • Jani BD, Hanlon P, Nicholl BI, et al. Relationship between multimorbidity, demographic factors and mortality: findings from the UK Biobank cohort. BMC Med. 2019;17(1):74. doi:10.1186/s12916-019-1305-x.
  • Insights Association. IA Code of Standards and Ethics for Marketing Research and Data Analytics. 2019. [cited 2020 June 17]. Available from: https://www.insightsassociation.org/issues-policies/insights-association-code-standards-and-ethics-market-research-and-data-analytics-0.
  • Battisti WP, Wager E, Baltzer L. International Society for Medical Publication Professionals, et al. Good publication practice for communicating company-sponsored medical research: GPP3. Ann Intern Med. 2015;163(6):461–464. doi:10.7326/m15-0288.